Parcion-Private-Wealth

Filing Details

13F-HR2025-03-31
Report Date
2025-03-31
Filing Date
2025-05-02
Total Holdings
393
Total Value
1226741402
Accession Number
0001801263-25-000005
Form Type
13F-HR
Manager Name
Parcion-Private-Wealth
Data Enrichment
89% identified
348 identified45 unidentified

Holdings

393 positions • $1.2B total value
Manager:
Search and click to pin securities to the top
Page 14 of 15
GILEAD SCIENCES, INC.
Shares:1.9K
Value:$218.2K
% of Portfolio:0.0% ($218.2K/$1.2B)
LOWES COMPANIES INC
Shares:929
Value:$216.7K
% of Portfolio:0.0% ($216.7K/$1.2B)
Crane Co
Shares:1.4K
Value:$216.6K
% of Portfolio:0.0% ($216.6K/$1.2B)
PENN Entertainment, Inc.
Shares:13.2K
Value:$215.0K
% of Portfolio:0.0% ($215.0K/$1.2B)
STRYKER CORP
Shares:574
Value:$213.7K
% of Portfolio:0.0% ($213.7K/$1.2B)
46137V456
Shares:4.0K
Value:$213.4K
% of Portfolio:0.0% ($213.4K/$1.2B)
Huntsman CORP
Shares:13.5K
Value:$212.6K
% of Portfolio:0.0% ($212.6K/$1.2B)
464286475
Shares:3.8K
Value:$212.3K
% of Portfolio:0.0% ($212.3K/$1.2B)
SYNOVUS FINANCIAL CORP
Shares:4.5K
Value:$211.1K
% of Portfolio:0.0% ($211.1K/$1.2B)
Chubb Ltd
Shares:696
Value:$210.2K
% of Portfolio:0.0% ($210.2K/$1.2B)
TransDigm Group INC
Shares:151
Value:$208.9K
% of Portfolio:0.0% ($208.9K/$1.2B)
Expedia Group, Inc.
Shares:1.2K
Value:$207.4K
% of Portfolio:0.0% ($207.4K/$1.2B)
67092P201
Shares:2.6K
Value:$206.7K
% of Portfolio:0.0% ($206.7K/$1.2B)
ALNYLAM PHARMACEUTICALS, INC.
Shares:748
Value:$202.0K
% of Portfolio:0.0% ($202.0K/$1.2B)
Nutanix, Inc.
Shares:2.9K
Value:$202.0K
% of Portfolio:0.0% ($202.0K/$1.2B)
LAMAR ADVERTISING CO/NEW
Shares:1.8K
Value:$200.7K
% of Portfolio:0.0% ($200.7K/$1.2B)
TAIWAN SEMICONDUCTOR MANUFACTURING CO LTD
Shares:1.2K
Value:$200.0K
% of Portfolio:0.0% ($200.0K/$1.2B)
HUNTINGTON BANCSHARES INC /MD/
Shares:12.3K
Value:$184.0K
% of Portfolio:0.0% ($184.0K/$1.2B)
POET TECHNOLOGIES INC.
Shares:45.0K
Value:$170.1K
% of Portfolio:0.0% ($170.1K/$1.2B)
Hewlett Packard Enterprise Co
Shares:10.6K
Value:$164.2K
% of Portfolio:0.0% ($164.2K/$1.2B)